1085454-10-9

Basic information

• Product Name: 5-[5-methyl-1-(4-{[tris(1-methylethyl)silyl]oxy}benzyl)-1H-pyrazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole
• Synonyms: 5-[5-methyl-1-(4-{[tris(1-methylethyl)silyl]oxy}benzyl)-1H-pyrazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole
• CAS NO: 1085454-10-9
• Molecular Weight: 572.703
• Mol File: 1085454-10-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-[5-methyl-1-(4-{[tris(1-methylethyl)silyl]oxy}benzyl)-1H-pyrazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[5-methyl-1-(4-{[tris(1-methylethyl)silyl]oxy}benzyl)-1H-pyrazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole(1085454-10-9)
• EPA Substance Registry System: 5-[5-methyl-1-(4-{[tris(1-methylethyl)silyl]oxy}benzyl)-1H-pyrazol-3-yl]-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole(1085454-10-9)

Safety Data

• Hazardous Substances Data: 1085454-10-9(Hazardous Substances Data)

Upstream product

• 20577-61-1 methyl 2,4-dioxopentanoate 
• 1085453-61-7 ethyl 4-(triisopropylsilyloxy)benzoate 
• 856905-30-1 5-methyl-1-(4-methylbenzyl)-1H-pyrazole-3-carboxylic acid 
• 1085453-45-7 methyl 5-methyl-1-(4-methylbenzyl)-1H-pyrazole-3-carboxylate 
• 13154-24-0 triisopropylsilyl chloride 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 1085453-46-8 5-(5-methyl-1H-pyrazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole 
• 611182-78-6 [4-(bromomethyl)phenoxy][tri(propan-2-yl)]silane 

Downstream Products

• 1085452-89-6 4-[(5-methyl-3-{3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl}-1H-pyrazol-1-yl)methyl]phenol 

Relevant articles and documents

HETEROARYL SUBSTITUTED PYRAZOLE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS

This invention relates to novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients or therapeutic measures.